BioMedNewsBreaks – InvestorBrandNetwork Heightening Visibility, Widening Reach of Roth Capital Partners’ Healthcare Private Company Forum

InvestorBrandNetwork (“IBN”), an innovative corporate communications firm and content distributor, today announced that it is continuing its collaboration with Roth Capital Partners (“Roth”) for its Virtual Healthcare Private Company Forum. The event is shining the spotlight on a diverse selection of companies across biotechnology, pharmaceuticals and medical technologies verticals and featuring engaging discussion panels designed to offer novel insights into some of the latest developments within the healthcare space. The panels will cover a number of topics, including “Novel Approaches to Tumor Eradication,” “Natural Killer Cell Approaches to Eradicate Tumors,” and the “Next Wave of Psychedelic Drug Developers.” IBN, operating in the capacity of media sponsor, is furthering distribution of content generated for the event. “Our team is excited to be collaborating once again with the Roth Capital team for today’s Virtual Healthcare Private Company Forum,” said Jonathan Keim, communications director for IBN. “We are leveraging our communications solutions to heighten visibility of the event and also widen the reach to additional investor audiences who would be interested in learning more about the participating companies.”

To view the full press release, visit https://ibn.fm/MXTSQ

About InvestorBrandNetwork

The InvestorBrandNetwork consists of financial brands introduced to the investment public over the course of more than 15 years. IBN has amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand its branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve its increasingly diversified list of clients. For more information on IBN, visit www.investorbrandnetwork.com.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork